A Large Room for Improvement Concerning the Management of Relapsed Refractory Large B-cell Lymphoma in Türkiye: Real-World Outcomes in the Setting Without Access to T-Cell Redirecting Therapies

The current therapeutic strategy of intensive chemoimmunotherapy followed by autologous transplantation yields a reasonable chance of survival for only one-fifth of patients. The findings of this study emphasize the urgent need for expanding access to T-cell redirecting approaches in R/R LBCL for early progressors, transplant-ineligible cases, and patients who fail intensive second-line regimens.

Authors

Institutions

Publication Details

Journal
Turkish Journal of Hematology
Published
2025-11-07
DOI
https://doi.org/10.4274/tjh.galenos.2025.2025.0352
Citations
1
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.47
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Large Room for Improvement Concerning the Management of Relapsed Refractory Large B-cell Lymphoma in Türkiye: Real-World Outcomes in the Setting Without Access to T-Cell Redirecting Therapies

Fevzi Altuntaş, Turgay Ulaş, Fatma Keklik Karadağ, Işık Atagündüz et al.
1 citations
Turkish Journal of Hematology
Lymphoma Diagnosis and Treatment
1.47
article

A Large Room for Improvement Concerning the Management of Relapsed Refractory Large B-cell Lymphoma in Türkiye: Real-World Outcomes in the Setting Without Access to T-Cell Redirecting Therapies

Fevzi Altuntaş, Turgay Ulaş, Fatma Keklik Karadağ, Işık Atagündüz, Eda Nuhoğlu Kantarcı, Tuğrul Elverdi, Meral Uluköylü Mengüç, Deniz Gören, Olga Meltem Akay, Elif Birtaş Ateşoğlu, Burhan Ferhanoğlu, Sinem Civriz Bozdağ, Ebru Pekgüç, Öner Doğan, Umur Hatipoğlu, Simge Erdem, Abdülkadir Şahin, Emre Osmanbaşoğlu, Derya Demir, Asu Fergün Yılmaz, Serdar Örnek, Nurullah Okumuş, Mustafa Nuri Yenerel, Mustafa Murat Özbalak, Özgür Mehtap, Muhlis Cem Ar, Güray Saydam, Taner Tan, Mert Seyhan, Umut Yılmaz, Tayfur Toptaş, Mehmet Sinan Dal, Tuğba Zorlu, Esra Terzi Demirsoy, Ali Durdu, Merve Apaydın Kayer, Ahmet Bahadır Ak
article en
1 citations

Abstract

The current therapeutic strategy of intensive chemoimmunotherapy followed by autologous transplantation yields a reasonable chance of survival for only one-fifth of patients. The findings of this study emphasize the urgent need for expanding access to T-cell redirecting approaches in R/R LBCL for early progressors, transplant-ineligible cases, and patients who fail intensive second-line regimens.

Turkish Journal of HematologyVol. 42(4)
Yeditepe University (TR), Koç University (TR), Ankara University (TR), University of Health Science (KH), Ege University (TR), Ankara Onkoloji Eğitim ve Araştırma Hastanesi (TR), Memorial Sisli Hospital (TR), Istanbul University-Cerrahpaşa (TR), Sağlık Bilimleri Üniversitesi (TR), Ankara Yıldırım Beyazıt University (TR), Amerikan Hastanesi (TR), Kocaeli Üniversitesi (TR), Istanbul University (TR), Marmara University (TR)
Openalex Percentile: Top 14%
Lymphoma Diagnosis and Treatment
1.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.